Combination Medical Therapy ( -Blockade and Androgen Suppression) in the Treatment of Benign Prostatic Hyperplasia
This is a prospective study designed to compare the outcome of two different lines of medical therapy for Benign Prostatic Hyperplasia (BPH), namely: blockers alone versus blockers and androgen suppressors in combination. One hundred patients were included in the study, which was conducted durin...
Main Authors: | Safwan A. Taha, Ziad Al-Naieb, Mortadha M Saleh |
---|---|
Format: | Article |
Language: | English |
Published: |
university of basrah
2002-12-01
|
Series: | Basrah Journal of Surgery |
Online Access: | https://bjsrg.uobasrah.edu.iq/article_55192_a06a907118d4122f92d201203c99b014.pdf |
Similar Items
-
The concentration of androgens and estrogens in benign prostatic hyperplasia
by: G. E. Roitberg, et al.
Published: (2021-02-01) -
Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
by: Trivunić-Dajko Sandra, et al.
Published: (2020-01-01) -
Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia
by: Yu Tong, et al.
Published: (2020-01-01) -
Is There a Relationship between Androgenic Alopecia and Benign Prostatic Hyperplasia?
by: Ladan Dastgheib, et al.
Published: (2015-01-01) -
Combination therapy in patients with benign prostatic hyperplasia
by: Bojan Tršinar
Published: (2006-11-01)